POLITICS
01/20/2013 02:20 pm ET Updated Mar 22, 2013

Fiscal Footnote: Big Senate Gift to Drug Maker

WASHINGTON — Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the “fiscal cliff” bill that did not mention the company by name but strongly favored one of its drugs.

Read more on nytimes.com

Subscribe to the Politics email.
How will Trump’s administration impact you?